Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Vontobel Won’t Abandon BB Biotech Bid, SonntagsZeitung Reports

Don't Miss Out —
Follow us on:

July 22 (Bloomberg) -- Vontobel Holding AG will persist with its bid to buy BB Biotech AG after an initial offer was rejected, SonntagsZeitung reported, citing Vontobel’s head of corporate finance Hanspeter Gehrer.

BB Biotech shareholders in Switzerland and abroad have encouraged Vontobel to continue pursuing the takeover, the Swiss newspaper quoted Gehrer as saying.

To contact the reporter on this story: Leigh Baldwin in Zurich at

To contact the editor responsible for this story: Mariajose Vera at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.